The global molecular weight market is accounted for USD 531 Million for the year 2020 and is expected to reach USD1,362.43Million for the year 2028 according to analysts at Vantage Market Research. Molecular weight markers are used in gel electrophoresis for the finding of the size of the molecule. The molecular weight market is driven by the factors such as increased biotechnology and pharmaceutical companies and increasing research and development.
Since the outbreak of the COVID-19, It has widely spread all over the world and has impacted many countries' economies, and caused huge losses in businesses. The molecular weight market is experiencing positive growth due to increased application in pharmaceutical and biotechnological industries.
The molecular weight market is segmented on the basis of product, type, end-user, and application. The type segment is further bifurcated into specialty markers, pre-stained markers, and unstained markers. The pre-stained sector is holding the largest share and shows potential growth in future forecasts. The product segment is divided into DNA markers, protein markers, and RNA markers. Based on end-user, the market is bifurcated into pharmaceutical, academic research, and biotechnology industries. The pharmaceutical has the largest share and potential growth for further forecasted years.
The major players for the molecular weight market are Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories, Agilent Technologies, F. Hoffmann-La Roche Ltd., Takara Bio, Inc., Qiagen N.V., Promega Corporation, New England Biolabs, Inc. and Affymetrix, Inc.
Regionally, the market is segmented as Asia-Pacific, Europe, North America, the Middle East, and Africa, and Latin America. North America attained the highest share due to the presence of key players and government initiatives. Asia-Pacific is also gaining the market share as emerging economies and increasing pharmaceutical industries are present in the region. In the coming years, the molecular weight market in Asia is predicted to rise at a rapid pace. This is owing to the increasing number of biotechnology companies that are establishing production facilities in the region. Furthermore, the region's market is being driven by the developing life science infrastructure. The global molecular weight market is being driven by the incidence of chronic diseases that demand molecular biomarkers for therapy. In addition, the worldwide molecular weight marker market is benefiting from increased government assistance in the form of investment in the life science field.